[
  {
    "CRI": [
      {
        "Abatacept": [
          {
            "Annexes": [
              {
                "Exemple de lettre d’information du…": [
                  {
                    "ABA_22_Lettre_Rhumato_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/Abatacept/Annexes/Exemple-de-lettre-d’information-du…/ABA_22_Lettre_Rhumato.pdf"
                  },
                  {
                    "ABA_23_Lettre_MG_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/Abatacept/Annexes/Exemple-de-lettre-d’information-du…/ABA_23_Lettre_MG.pdf"
                  }
                ]
              }
            ]
          },
          {
            "Autres maladies (hors PR)": [
              {
                "Utilisation de l’abatacept dans_": [
                  {
                    "ABA_19_AJI_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/Abatacept/Autres-maladies-(hors-PR)/Utilisation-de-l’abatacept-dans/ABA_19_AJI.pdf"
                  },
                  {
                    "ABA_20_SPA_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/Abatacept/Autres-maladies-(hors-PR)/Utilisation-de-l’abatacept-dans/ABA_20_SPA.pdf"
                  },
                  {
                    "ABA_21_MAI_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/Abatacept/Autres-maladies-(hors-PR)/Utilisation-de-l’abatacept-dans/ABA_21_MAI.pdf"
                  }
                ]
              }
            ]
          },
          {
            "Polyarthrite Rhumatoïde": [
              {
                "Initiation de l’abatacept et suivi": [
                  {
                    "ABA_01_Bilan_pre-therapeutique_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/Abatacept/Polyarthrite-Rhumatoide/Initiation-de-l’abatacept-et-suivi/ABA_01_Bilan_pre-therapeutique.pdf"
                  },
                  {
                    "ABA_02_Suivi_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/Abatacept/Polyarthrite-Rhumatoide/Initiation-de-l’abatacept-et-suivi/ABA_02_Suivi.pdf"
                  }
                ]
              },
              {
                "L'abatacept en injection sous-cutanée": [
                  {
                    "ABA_17_Inj_Sous_Cut_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/Abatacept/Polyarthrite-Rhumatoide/Labatacept-en-injection-sous-cutanee/ABA_17_Inj_Sous_Cut.pdf"
                  }
                ]
              },
              {
                "Pathologies : que faire en cas d'antécédents ou d'apparition de_ ?": [
                  {
                    "ABA_03_Affections_auto-immunes_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/Abatacept/Polyarthrite-Rhumatoide/Pathologies-que-faire-en-cas-dantecedents-ou-dapparition-de/ABA_03_Affections_auto-immunes.pdf"
                  },
                  {
                    "ABA_04_Affections_cardiovasculaires_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/Abatacept/Polyarthrite-Rhumatoide/Pathologies-que-faire-en-cas-dantecedents-ou-dapparition-de/ABA_04_Affections_cardiovasculaires.pdf"
                  },
                  {
                    "ABA_05_Affections_hematologiques_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/Abatacept/Polyarthrite-Rhumatoide/Pathologies-que-faire-en-cas-dantecedents-ou-dapparition-de/ABA_05_Affections_hematologiques.pdf"
                  },
                  {
                    "ABA_06_Anomalies_hepatiques_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/Abatacept/Polyarthrite-Rhumatoide/Pathologies-que-faire-en-cas-dantecedents-ou-dapparition-de/ABA_06_Anomalies_hepatiques.pdf"
                  },
                  {
                    "ABA_07_Infections_bact_vir_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/Abatacept/Polyarthrite-Rhumatoide/Pathologies-que-faire-en-cas-dantecedents-ou-dapparition-de/ABA_07_Infections_bact_vir.pdf"
                  },
                  {
                    "ABA_08_Neoplasies_solides_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/Abatacept/Polyarthrite-Rhumatoide/Pathologies-que-faire-en-cas-dantecedents-ou-dapparition-de/ABA_08_Neoplasies_solides.pdf"
                  },
                  {
                    "ABA_09_Reactions_perfusion_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/Abatacept/Polyarthrite-Rhumatoide/Pathologies-que-faire-en-cas-dantecedents-ou-dapparition-de/ABA_09_Reactions_perfusion.pdf"
                  }
                ]
              },
              {
                "Situations cliniques : conduite à tenir en cas de_": [
                  {
                    "ABA_10_Situations_particulieres_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/Abatacept/Polyarthrite-Rhumatoide/Situations-cliniques-conduite-a-tenir-en-cas-de/ABA_10_Situations_particulieres.pdf"
                  },
                  {
                    "ABA_11_Associations_medicamenteuses_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/Abatacept/Polyarthrite-Rhumatoide/Situations-cliniques-conduite-a-tenir-en-cas-de/ABA_11_Associations_medicamenteuses.pdf"
                  },
                  {
                    "ABA_12_Chirurgie_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/Abatacept/Polyarthrite-Rhumatoide/Situations-cliniques-conduite-a-tenir-en-cas-de/ABA_12_Chirurgie.pdf"
                  },
                  {
                    "ABA_13_Grossesse_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/Abatacept/Polyarthrite-Rhumatoide/Situations-cliniques-conduite-a-tenir-en-cas-de/ABA_13_Grossesse.pdf"
                  },
                  {
                    "ABA_14_Sujet_age_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/Abatacept/Polyarthrite-Rhumatoide/Situations-cliniques-conduite-a-tenir-en-cas-de/ABA_14_Sujet_age.pdf"
                  },
                  {
                    "ABA_15_Vaccination_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/Abatacept/Polyarthrite-Rhumatoide/Situations-cliniques-conduite-a-tenir-en-cas-de/ABA_15_Vaccination.pdf"
                  },
                  {
                    "ABA_16_Voyage_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/Abatacept/Polyarthrite-Rhumatoide/Situations-cliniques-conduite-a-tenir-en-cas-de/ABA_16_Voyage.pdf"
                  }
                ]
              },
              {
                "Utilisation de l’abatacept dans la PR": [
                  {
                    "ABA_18_Info_patient_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/Abatacept/Polyarthrite-Rhumatoide/Utilisation-de-l’abatacept-dans-la-PR/ABA_18_Info_patient.pdf"
                  }
                ]
              }
            ]
          }
        ]
      },
      {
        "Anti-IL6R": [
          {
            "Comment suivre et optimiser le traitement d’un patient sous anti-IL6R ?": [
              {
                "Anti_IL6_Suivi_Optimisation_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/Anti-IL6R/Comment-suivre-et-optimiser-le-traitement-d’un-patient-sous-anti-IL6R/Anti_IL6_Suivi_Optimisation.pdf"
              }
            ]
          },
          {
            "Comment utiliser les anti-IL6R :": [
              {
                "Anti_IL6R_AJI_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/Anti-IL6R/Comment-utiliser-les-anti-IL6R-/Anti_IL6R_AJI.pdf"
              },
              {
                "Anti_IL6R_Horton_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/Anti-IL6R/Comment-utiliser-les-anti-IL6R-/Anti_IL6R_Horton.pdf"
              }
            ]
          },
          {
            "Conduite à tenir en cas :": [
              {
                "Anti_IL6R_Asso_Med_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/Anti-IL6R/Conduite-a-tenir-en-cas-/Anti_IL6R_Asso_Med.pdf"
              },
              {
                "Anti_IL6R_Chirurgie_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/Anti-IL6R/Conduite-a-tenir-en-cas-/Anti_IL6R_Chirurgie.pdf"
              },
              {
                "Anti_IL6R_Grossesse_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/Anti-IL6R/Conduite-a-tenir-en-cas-/Anti_IL6R_Grossesse.pdf"
              },
              {
                "Anti_IL6R_Infection_BK_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/Anti-IL6R/Conduite-a-tenir-en-cas-/Anti_IL6R_Infection_BK.pdf"
              },
              {
                "Anti_IL6R_Infections_ViroBacterio_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/Anti-IL6R/Conduite-a-tenir-en-cas-/Anti_IL6R_Infections_ViroBacterio.pdf"
              },
              {
                "Anti_IL6R_Pathologie_pulmonaire_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/Anti-IL6R/Conduite-a-tenir-en-cas-/Anti_IL6R_Pathologie_pulmonaire.pdf"
              },
              {
                "Anti_IL6R_Tatouage_Piercing_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/Anti-IL6R/Conduite-a-tenir-en-cas-/Anti_IL6R_Tatouage_Piercing.pdf"
              },
              {
                "Anti_IL6R_Vaccination_V2_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/Anti-IL6R/Conduite-a-tenir-en-cas-/Anti_IL6R_Vaccination_V2.pdf"
              },
              {
                "Anti_IL6R_Voyage_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/Anti-IL6R/Conduite-a-tenir-en-cas-/Anti_IL6R_Voyage.pdf"
              },
              {
                "Anti_IL6R_situations_part_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/Anti-IL6R/Conduite-a-tenir-en-cas-/Anti_IL6R_situations_part.pdf"
              }
            ]
          },
          {
            "Que faire avant d’initier un anti-IL16R ?": [
              {
                "Anti_IL6R_Bilan_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/Anti-IL6R/Que-faire-avant-d’initier-un-anti-IL16R/Anti_IL6R_Bilan.pdf"
              }
            ]
          },
          {
            "Que faire en cas d’antécédent ou d’apparition :": [
              {
                "Anti_IL6R_Affections_Auto_Immu_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/Anti-IL6R/Que-faire-en-cas-d’antecedent-ou-d’apparition-/Anti_IL6R_Affections_Auto_Immu.pdf"
              },
              {
                "Anti_IL6R_Cardio_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/Anti-IL6R/Que-faire-en-cas-d’antecedent-ou-d’apparition-/Anti_IL6R_Cardio.pdf"
              },
              {
                "Anti_IL6R_Hemato_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/Anti-IL6R/Que-faire-en-cas-d’antecedent-ou-d’apparition-/Anti_IL6R_Hemato.pdf"
              },
              {
                "Anti_IL6R_Neoplasies_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/Anti-IL6R/Que-faire-en-cas-d’antecedent-ou-d’apparition-/Anti_IL6R_Neoplasies.pdf"
              },
              {
                "Anti_IL6R_Patho_Ileo_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/Anti-IL6R/Que-faire-en-cas-d’antecedent-ou-d’apparition-/Anti_IL6R_Patho_Ileo.pdf"
              },
              {
                "Anti_IL6R_Reaction_Cutanee_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/Anti-IL6R/Que-faire-en-cas-d’antecedent-ou-d’apparition-/Anti_IL6R_Reaction_Cutanee.pdf"
              },
              {
                "Anti_IL6_Hepato_08062021_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/Anti-IL6R/Que-faire-en-cas-d’antecedent-ou-d’apparition-/Anti_IL6_Hepato_08062021.pdf"
              }
            ]
          }
        ]
      },
      {
        "Hydroxychloroquine": [
          {
            "Prise en charge des patients sous hydroxychloroquine": [
              {
                "A quelle dose prescrire ?": [
                  {
                    "Plaquenil_Dosage_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/Hydroxychloroquine/Prise-en-charge-des-patients-sous-hydroxychloroquine/A-quelle-dose-prescrire/Plaquenil_Dosage.pdf"
                  }
                ]
              },
              {
                "Comment suivre et optimiser le traitement d’un patient sous anti-IL17 ?": [
                  {
                    "Plaquenil_Optimiser_efficacite_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/Hydroxychloroquine/Prise-en-charge-des-patients-sous-hydroxychloroquine/Comment-suivre-et-optimiser-le-traitement-d’un-patient-sous-anti-IL17/Plaquenil_Optimiser_efficacite.pdf"
                  }
                ]
              },
              {
                "Comment suivre un patient traité par hydroxychloroquine ?": [
                  {
                    "Plaquenil_Suivi_patient_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/Hydroxychloroquine/Prise-en-charge-des-patients-sous-hydroxychloroquine/Comment-suivre-un-patient-traite-par-hydroxychloroquine/Plaquenil_Suivi_patient.pdf"
                  }
                ]
              },
              {
                "Conduite à tenir en cas :": [
                  {
                    "Plaquenil_Associations_medicamenteuses_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/Hydroxychloroquine/Prise-en-charge-des-patients-sous-hydroxychloroquine/Conduite-a-tenir-en-cas-/Plaquenil_Associations_medicamenteuses.pdf"
                  },
                  {
                    "Plaquenil_Contraception_grossesse_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/Hydroxychloroquine/Prise-en-charge-des-patients-sous-hydroxychloroquine/Conduite-a-tenir-en-cas-/Plaquenil_Contraception_grossesse.pdf"
                  },
                  {
                    "Plaquenil_Situations_particulieres_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/Hydroxychloroquine/Prise-en-charge-des-patients-sous-hydroxychloroquine/Conduite-a-tenir-en-cas-/Plaquenil_Situations_particulieres.pdf"
                  }
                ]
              },
              {
                "Effets secondaires de l’hydroxychloroquine hors atteinte ophtalmologique et leur prise en charge": [
                  {
                    "Plaquenil_Effets_secondaires_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/Hydroxychloroquine/Prise-en-charge-des-patients-sous-hydroxychloroquine/Effets-secondaires-de-l’hydroxychloroquine-hors-atteinte-ophtalmologique-et-leur-prise-en-charge/Plaquenil_Effets_secondaires.pdf"
                  }
                ]
              },
              {
                "Fiche d'information à destination des patients": [
                  {
                    "Plaquenil_Information_patients_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/Hydroxychloroquine/Prise-en-charge-des-patients-sous-hydroxychloroquine/Fiche-dinformation-a-destination-des-patients/Plaquenil_Information_patients.pdf"
                  }
                ]
              },
              {
                "Que faire avant d’initier un traitement par hydroxychloroquine ?": [
                  {
                    "Plaquenil_Bilan_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/Hydroxychloroquine/Prise-en-charge-des-patients-sous-hydroxychloroquine/Que-faire-avant-d’initier-un-traitement-par-hydroxychloroquine/Plaquenil_Bilan.pdf"
                  }
                ]
              }
            ]
          }
        ]
      },
      {
        "Méthotrexate": [
          {
            "Annexes": [
              {
                "Exemple de lettre d'information du_": [
                  {
                    "MTX_22_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/Methotrexate/Annexes/Exemple-de-lettre-dinformation-du/MTX_22.pdf"
                  },
                  {
                    "MTX_23_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/Methotrexate/Annexes/Exemple-de-lettre-dinformation-du/MTX_23.pdf"
                  }
                ]
              }
            ]
          },
          {
            "Autres maladies (hors PR)": [
              {
                "Comment utiliser le méthotrexate dans_": [
                  {
                    "MTX_18_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/Methotrexate/Autres-maladies-(hors-PR)/Comment-utiliser-le-methotrexate-dans/MTX_18.pdf"
                  },
                  {
                    "MTX_19_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/Methotrexate/Autres-maladies-(hors-PR)/Comment-utiliser-le-methotrexate-dans/MTX_19.pdf"
                  },
                  {
                    "MTX_20_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/Methotrexate/Autres-maladies-(hors-PR)/Comment-utiliser-le-methotrexate-dans/MTX_20.pdf"
                  },
                  {
                    "MTX_21_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/Methotrexate/Autres-maladies-(hors-PR)/Comment-utiliser-le-methotrexate-dans/MTX_21.pdf"
                  }
                ]
              }
            ]
          },
          {
            "Polyarthrite rhumatoïde (PR)": [
              {
                "Comment optimiser l’efficacité du méthotrexate ? ": [
                  {
                    "MTX_02_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/Methotrexate/Polyarthrite-rhumatoide-(PR)/Comment-optimiser-l’efficacite-du-methotrexate/MTX_02.pdf"
                  }
                ]
              },
              {
                "Comment suivre un patient traité par méthotrexate ?": [
                  {
                    "MTX_03_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/Methotrexate/Polyarthrite-rhumatoide-(PR)/Comment-suivre-un-patient-traite-par-methotrexate/MTX_03.pdf"
                  }
                ]
              },
              {
                "Pathologies : que faire en cas d’antécédent ou d’apparition de_": [
                  {
                    "MTX_04_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/Methotrexate/Polyarthrite-rhumatoide-(PR)/Pathologies--que-faire-en-cas-d’antecedent-ou-d’apparition-de/MTX_04.pdf"
                  },
                  {
                    "MTX_05_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/Methotrexate/Polyarthrite-rhumatoide-(PR)/Pathologies--que-faire-en-cas-d’antecedent-ou-d’apparition-de/MTX_05.pdf"
                  },
                  {
                    "MTX_06_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/Methotrexate/Polyarthrite-rhumatoide-(PR)/Pathologies--que-faire-en-cas-d’antecedent-ou-d’apparition-de/MTX_06.pdf"
                  },
                  {
                    "MTX_07_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/Methotrexate/Polyarthrite-rhumatoide-(PR)/Pathologies--que-faire-en-cas-d’antecedent-ou-d’apparition-de/MTX_07.pdf"
                  },
                  {
                    "MTX_08_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/Methotrexate/Polyarthrite-rhumatoide-(PR)/Pathologies--que-faire-en-cas-d’antecedent-ou-d’apparition-de/MTX_08.pdf"
                  },
                  {
                    "MTX_09_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/Methotrexate/Polyarthrite-rhumatoide-(PR)/Pathologies--que-faire-en-cas-d’antecedent-ou-d’apparition-de/MTX_09.pdf"
                  },
                  {
                    "MTX_10_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/Methotrexate/Polyarthrite-rhumatoide-(PR)/Pathologies--que-faire-en-cas-d’antecedent-ou-d’apparition-de/MTX_10.pdf"
                  }
                ]
              },
              {
                "Que faire avant d’initier le méthotrexate ?": [
                  {
                    "MTX_01_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/Methotrexate/Polyarthrite-rhumatoide-(PR)/Que-faire-avant-d’initier-le-methotrexate/MTX_01.pdf"
                  }
                ]
              },
              {
                "Situations cliniques : quelle conduite à tenir en cas de_": [
                  {
                    "MTX_11_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/Methotrexate/Polyarthrite-rhumatoide-(PR)/Situations-cliniques--quelle-conduite-a-tenir-en-cas-de/MTX_11.pdf"
                  },
                  {
                    "MTX_12_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/Methotrexate/Polyarthrite-rhumatoide-(PR)/Situations-cliniques--quelle-conduite-a-tenir-en-cas-de/MTX_12.pdf"
                  },
                  {
                    "MTX_13_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/Methotrexate/Polyarthrite-rhumatoide-(PR)/Situations-cliniques--quelle-conduite-a-tenir-en-cas-de/MTX_13.pdf"
                  },
                  {
                    "MTX_14_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/Methotrexate/Polyarthrite-rhumatoide-(PR)/Situations-cliniques--quelle-conduite-a-tenir-en-cas-de/MTX_14.pdf"
                  },
                  {
                    "MTX_15_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/Methotrexate/Polyarthrite-rhumatoide-(PR)/Situations-cliniques--quelle-conduite-a-tenir-en-cas-de/MTX_15.pdf"
                  },
                  {
                    "MTX_16_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/Methotrexate/Polyarthrite-rhumatoide-(PR)/Situations-cliniques--quelle-conduite-a-tenir-en-cas-de/MTX_16.pdf"
                  },
                  {
                    "MTX_17_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/Methotrexate/Polyarthrite-rhumatoide-(PR)/Situations-cliniques--quelle-conduite-a-tenir-en-cas-de/MTX_17.pdf"
                  }
                ]
              }
            ]
          }
        ]
      },
      {
        "Rituximab": [
          {
            "Chez l'enfant": [
              {
                "RTX_Pediatrie_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/Rituximab/Chez-lenfant/RTX_Pediatrie.pdf"
              }
            ]
          },
          {
            "Dans la polyarthrite rhumatoïde": [
              {
                "Ce que nous apprend le registre AIR": [
                  {
                    "RTX_17_Registre_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/Rituximab/Dans-la-polyarthrite-rhumatoide/Ce-que-nous-apprend-le-registre-AIR/RTX_17_Registre.pdf"
                  }
                ]
              },
              {
                "Comment retraiter un patient traité par rituximab ?": [
                  {
                    "RTX_03_Retraitement_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/Rituximab/Dans-la-polyarthrite-rhumatoide/Comment-retraiter-un-patient-traite-par-rituximab/RTX_03_Retraitement.pdf"
                  }
                ]
              },
              {
                "Comment suivre un patient traité par rituximab ?": [
                  {
                    "RTX_02_Traitement_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/Rituximab/Dans-la-polyarthrite-rhumatoide/Comment-suivre-un-patient-traite-par-rituximab/RTX_02_Traitement.pdf"
                  }
                ]
              },
              {
                "Exemple de lettre d'information pour_": [
                  {
                    "RTX_18_Rhumatologue_traitant_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/Rituximab/Dans-la-polyarthrite-rhumatoide/Exemple-de-lettre-dinformation-pour/RTX_18_Rhumatologue_traitant.pdf"
                  },
                  {
                    "RTX_19_Medecin_traitant_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/Rituximab/Dans-la-polyarthrite-rhumatoide/Exemple-de-lettre-dinformation-pour/RTX_19_Medecin_traitant.pdf"
                  },
                  {
                    "RTX_20 Info_patient_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/Rituximab/Dans-la-polyarthrite-rhumatoide/Exemple-de-lettre-dinformation-pour/RTX_20 Info_patient.pdf"
                  }
                ]
              },
              {
                "Pathologies : que faire en cas d’antécédents ou d’apparition de_ ?": [
                  {
                    "RTX_03_Retraitement_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/Rituximab/Dans-la-polyarthrite-rhumatoide/Pathologies--que-faire-en-cas-d’antecedents-ou-d’apparition-de/RTX_03_Retraitement.pdf"
                  },
                  {
                    "RTX_04_Infections_bacteriennes_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/Rituximab/Dans-la-polyarthrite-rhumatoide/Pathologies--que-faire-en-cas-d’antecedents-ou-d’apparition-de/RTX_04_Infections_bacteriennes.pdf"
                  },
                  {
                    "RTX_05_Cardio_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/Rituximab/Dans-la-polyarthrite-rhumatoide/Pathologies--que-faire-en-cas-d’antecedents-ou-d’apparition-de/RTX_05_Cardio.pdf"
                  },
                  {
                    "RTX_06_Neoplasie_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/Rituximab/Dans-la-polyarthrite-rhumatoide/Pathologies--que-faire-en-cas-d’antecedents-ou-d’apparition-de/RTX_06_Neoplasie.pdf"
                  },
                  {
                    "RTX_07_Affections_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/Rituximab/Dans-la-polyarthrite-rhumatoide/Pathologies--que-faire-en-cas-d’antecedents-ou-d’apparition-de/RTX_07_Affections.pdf"
                  },
                  {
                    "RTX_08_Reactions_perfusion_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/Rituximab/Dans-la-polyarthrite-rhumatoide/Pathologies--que-faire-en-cas-d’antecedents-ou-d’apparition-de/RTX_08_Reactions_perfusion.pdf"
                  },
                  {
                    "RTX_09_Affections_du_SNC_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/Rituximab/Dans-la-polyarthrite-rhumatoide/Pathologies--que-faire-en-cas-d’antecedents-ou-d’apparition-de/RTX_09_Affections_du_SNC.pdf"
                  },
                  {
                    "RTX_10_Affections_pulmonaires_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/Rituximab/Dans-la-polyarthrite-rhumatoide/Pathologies--que-faire-en-cas-d’antecedents-ou-d’apparition-de/RTX_10_Affections_pulmonaires.pdf"
                  }
                ]
              },
              {
                "Que faire avant d’initier le rituximab ?": [
                  {
                    "RTX_01_Bilan_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/Rituximab/Dans-la-polyarthrite-rhumatoide/Que-faire-avant-d’initier-le-rituximab/RTX_01_Bilan.pdf"
                  }
                ]
              },
              {
                "Situations cliniques : conduite à tenir en cas de_": [
                  {
                    "RTX_11_Chirurgie_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/Rituximab/Dans-la-polyarthrite-rhumatoide/Situations-cliniques--conduite-a-tenir-en-cas-de/RTX_11_Chirurgie.pdf"
                  },
                  {
                    "RTX_12_Grossesse_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/Rituximab/Dans-la-polyarthrite-rhumatoide/Situations-cliniques--conduite-a-tenir-en-cas-de/RTX_12_Grossesse.pdf"
                  },
                  {
                    "RTX_13_Vaccination_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/Rituximab/Dans-la-polyarthrite-rhumatoide/Situations-cliniques--conduite-a-tenir-en-cas-de/RTX_13_Vaccination.pdf"
                  },
                  {
                    "RTX_14_Voyages_V2_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/Rituximab/Dans-la-polyarthrite-rhumatoide/Situations-cliniques--conduite-a-tenir-en-cas-de/RTX_14_Voyages_V2.pdf"
                  },
                  {
                    "RTX_15_Assoc_Medic_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/Rituximab/Dans-la-polyarthrite-rhumatoide/Situations-cliniques--conduite-a-tenir-en-cas-de/RTX_15_Assoc_Medic.pdf"
                  },
                  {
                    "RTX_16_Situations_Part_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/Rituximab/Dans-la-polyarthrite-rhumatoide/Situations-cliniques--conduite-a-tenir-en-cas-de/RTX_16_Situations_Part.pdf"
                  }
                ]
              }
            ]
          },
          {
            "Dans les autres maladies (hors PR)": [
              {
                "Comment utiliser le rituximab dans _": [
                  {
                    "RTX_21_Vascularites_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/Rituximab/Dans-les-autres-maladies-(hors-PR)/Comment-utiliser-le-rituximab-dans-/RTX_21_Vascularites.pdf"
                  },
                  {
                    "RTX_22_Utilisation_dans_les_MAI_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/Rituximab/Dans-les-autres-maladies-(hors-PR)/Comment-utiliser-le-rituximab-dans-/RTX_22_Utilisation_dans_les_MAI.pdf"
                  },
                  {
                    "RTX_23_AJI_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/Rituximab/Dans-les-autres-maladies-(hors-PR)/Comment-utiliser-le-rituximab-dans-/RTX_23_AJI.pdf"
                  }
                ]
              }
            ]
          }
        ]
      },
      {
        "Ustékinumab": [
          {
            "Dans le rhumatisme psoriasique et le psoriasis en plaques": [
              {
                "Comment optimiser le traitement par ustékinumab ?": [
                  {
                    "USK_03_Optimisation_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/Ustekinumab/Dans-le-rhumatisme-psoriasique-et-le-psoriasis-en-plaques/Comment-optimiser-le-traitement-par-ustekinumab/USK_03_Optimisation.pdf"
                  }
                ]
              },
              {
                "Comment suivre un patient traité par ustékinumab ?": [
                  {
                    "USK_02_Suivi_V2_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/Ustekinumab/Dans-le-rhumatisme-psoriasique-et-le-psoriasis-en-plaques/Comment-suivre-un-patient-traite-par-ustekinumab/USK_02_Suivi_V2.pdf"
                  }
                ]
              },
              {
                "Exemple de lettre d’information pour_": [
                  {
                    "USK_18_Lettre_Rhumato_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/Ustekinumab/Dans-le-rhumatisme-psoriasique-et-le-psoriasis-en-plaques/Exemple-de-lettre-d’information-pour/USK_18_Lettre_Rhumato.pdf"
                  },
                  {
                    "USK_19_Lettre_MG_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/Ustekinumab/Dans-le-rhumatisme-psoriasique-et-le-psoriasis-en-plaques/Exemple-de-lettre-d’information-pour/USK_19_Lettre_MG.pdf"
                  },
                  {
                    "USK_20_Lettre_Dermatologue_V2_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/Ustekinumab/Dans-le-rhumatisme-psoriasique-et-le-psoriasis-en-plaques/Exemple-de-lettre-d’information-pour/USK_20_Lettre_Dermatologue_V2.pdf"
                  },
                  {
                    "USK_21_Info_Patient_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/Ustekinumab/Dans-le-rhumatisme-psoriasique-et-le-psoriasis-en-plaques/Exemple-de-lettre-d’information-pour/USK_21_Info_Patient.pdf"
                  }
                ]
              },
              {
                "Pathologies : que faire en cas d’antécédent ou d’apparition de_": [
                  {
                    "USK_04_Infection_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/Ustekinumab/Dans-le-rhumatisme-psoriasique-et-le-psoriasis-en-plaques/Pathologies--que-faire-en-cas-d’antecedent-ou-d’apparition-de/USK_04_Infection.pdf"
                  },
                  {
                    "USK_05_Cardio_V2_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/Ustekinumab/Dans-le-rhumatisme-psoriasique-et-le-psoriasis-en-plaques/Pathologies--que-faire-en-cas-d’antecedent-ou-d’apparition-de/USK_05_Cardio_V2.pdf"
                  },
                  {
                    "USK_06_Cancer_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/Ustekinumab/Dans-le-rhumatisme-psoriasique-et-le-psoriasis-en-plaques/Pathologies--que-faire-en-cas-d’antecedent-ou-d’apparition-de/USK_06_Cancer.pdf"
                  },
                  {
                    "USK_07_Hemato_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/Ustekinumab/Dans-le-rhumatisme-psoriasique-et-le-psoriasis-en-plaques/Pathologies--que-faire-en-cas-d’antecedent-ou-d’apparition-de/USK_07_Hemato.pdf"
                  },
                  {
                    "USK_08_Cutane_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/Ustekinumab/Dans-le-rhumatisme-psoriasique-et-le-psoriasis-en-plaques/Pathologies--que-faire-en-cas-d’antecedent-ou-d’apparition-de/USK_08_Cutane.pdf"
                  },
                  {
                    "USK_09_Hepato_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/Ustekinumab/Dans-le-rhumatisme-psoriasique-et-le-psoriasis-en-plaques/Pathologies--que-faire-en-cas-d’antecedent-ou-d’apparition-de/USK_09_Hepato.pdf"
                  },
                  {
                    "USK_10 Aff_Autoimmunes_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/Ustekinumab/Dans-le-rhumatisme-psoriasique-et-le-psoriasis-en-plaques/Pathologies--que-faire-en-cas-d’antecedent-ou-d’apparition-de/USK_10 Aff_Autoimmunes.pdf"
                  }
                ]
              },
              {
                "Que faire avant d’initier l’ustékinumab ?": [
                  {
                    "USK_01_Bilan_V2_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/Ustekinumab/Dans-le-rhumatisme-psoriasique-et-le-psoriasis-en-plaques/Que-faire-avant-d’initier-l’ustekinumab/USK_01_Bilan_V2.pdf"
                  }
                ]
              },
              {
                "Situations cliniques : quelle conduite à tenir en cas de_": [
                  {
                    "USK_11_Chirurgie_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/Ustekinumab/Dans-le-rhumatisme-psoriasique-et-le-psoriasis-en-plaques/Situations-cliniques--quelle-conduite-a-tenir-en-cas-de/USK_11_Chirurgie.pdf"
                  },
                  {
                    "USK_12_Grossesse_V2_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/Ustekinumab/Dans-le-rhumatisme-psoriasique-et-le-psoriasis-en-plaques/Situations-cliniques--quelle-conduite-a-tenir-en-cas-de/USK_12_Grossesse_V2.pdf"
                  },
                  {
                    "USK_13_Vaccination_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/Ustekinumab/Dans-le-rhumatisme-psoriasique-et-le-psoriasis-en-plaques/Situations-cliniques--quelle-conduite-a-tenir-en-cas-de/USK_13_Vaccination.pdf"
                  },
                  {
                    "USK_14_Voyage_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/Ustekinumab/Dans-le-rhumatisme-psoriasique-et-le-psoriasis-en-plaques/Situations-cliniques--quelle-conduite-a-tenir-en-cas-de/USK_14_Voyage.pdf"
                  },
                  {
                    "USK_15_Association_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/Ustekinumab/Dans-le-rhumatisme-psoriasique-et-le-psoriasis-en-plaques/Situations-cliniques--quelle-conduite-a-tenir-en-cas-de/USK_15_Association.pdf"
                  },
                  {
                    "USK_16 Situations_particulieres_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/Ustekinumab/Dans-le-rhumatisme-psoriasique-et-le-psoriasis-en-plaques/Situations-cliniques--quelle-conduite-a-tenir-en-cas-de/USK_16 Situations_particulieres.pdf"
                  },
                  {
                    "USK_17_Sujets_ages_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/Ustekinumab/Dans-le-rhumatisme-psoriasique-et-le-psoriasis-en-plaques/Situations-cliniques--quelle-conduite-a-tenir-en-cas-de/USK_17_Sujets_ages.pdf"
                  }
                ]
              }
            ]
          },
          {
            "Dans les autres maladies": [
              {
                "Comment utiliser l’ustékinumab dans_": [
                  {
                    "USK_22_SPA_V2_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/Ustekinumab/Dans-les-autres-maladies/Comment-utiliser-l’ustekinumab-dans/USK_22_SPA_V2.pdf"
                  },
                  {
                    "USK_23_Crohn_V2_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/Ustekinumab/Dans-les-autres-maladies/Comment-utiliser-l’ustekinumab-dans/USK_23_Crohn_V2.pdf"
                  }
                ]
              }
            ]
          }
        ]
      },
      {
        "anti-IL1": [
          {
            "Annexes": [
              {
                "Exemple de lettre d’information du…": [
                  {
                    "F19_RHUMATO-INTERNISTE-TRAITANT_ANTI-IL1_VDEF_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/anti-IL1/Annexes/Exemple-de-lettre-d’information-du…/F19_RHUMATO-INTERNISTE-TRAITANT_ANTI-IL1_VDEF.pdf"
                  },
                  {
                    "F20_PEDIATRE-MED-TRAITANT_ANTI-IL1_VDEF_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/anti-IL1/Annexes/Exemple-de-lettre-d’information-du…/F20_PEDIATRE-MED-TRAITANT_ANTI-IL1_VDEF.pdf"
                  }
                ]
              }
            ]
          },
          {
            "Autres maladies (hors PR)": [
              {
                "Utilisation des anti-IL1 _": [
                  {
                    "F16_FSAJI_ANTI-IL1_VDEF_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/anti-IL1/Autres-maladies-(hors-PR)/Utilisation-des-anti-IL1-/F16_FSAJI_ANTI-IL1_VDEF.pdf"
                  },
                  {
                    "F17_MALADIE-AUTO-INFLAMMATOIRE_ANTI-IL1_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/anti-IL1/Autres-maladies-(hors-PR)/Utilisation-des-anti-IL1-/F17_MALADIE-AUTO-INFLAMMATOIRE_ANTI-IL1.pdf"
                  }
                ]
              }
            ]
          },
          {
            "Polyarthrite Rhumatoïde": [
              {
                "Bilan pré-thérapeutique et suivi d’un patient (adulte ou enfant) sous Anti-IL1": [
                  {
                    "F1_BILAN-SUIVI_ANTI-IL1_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/anti-IL1/Polyarthrite-Rhumatoide/Bilan-pre-therapeutique-et-suivi-d’un-patient-(adulte-ou-enfant)-sous-Anti-IL1/F1_BILAN-SUIVI_ANTI-IL1.pdf"
                  }
                ]
              },
              {
                "Pathologies : que faire en cas d’antécédents ou d’apparition de_ ?": [
                  {
                    "F2_INFECTIONS-BACTERIENNES-OU-VIRALES_ANTI-IL1_VDEF_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/anti-IL1/Polyarthrite-Rhumatoide/Pathologies-que-faire-en-cas-d’antecedents-ou-d’apparition-de/F2_INFECTIONS-BACTERIENNES-OU-VIRALES_ANTI-IL1_VDEF.pdf"
                  },
                  {
                    "F3_NEOPLASIE-SOLIDE-ET-HEMATOLOGIQUE_ANTI-IL1_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/anti-IL1/Polyarthrite-Rhumatoide/Pathologies-que-faire-en-cas-d’antecedents-ou-d’apparition-de/F3_NEOPLASIE-SOLIDE-ET-HEMATOLOGIQUE_ANTI-IL1.pdf"
                  },
                  {
                    "F4_AFFECTIONS-CARDIOVASCULAIRE_ANTI-IL1_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/anti-IL1/Polyarthrite-Rhumatoide/Pathologies-que-faire-en-cas-d’antecedents-ou-d’apparition-de/F4_AFFECTIONS-CARDIOVASCULAIRE_ANTI-IL1.pdf"
                  },
                  {
                    "F5_REACTIONS-CUTANEES_ANTI-IL1_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/anti-IL1/Polyarthrite-Rhumatoide/Pathologies-que-faire-en-cas-d’antecedents-ou-d’apparition-de/F5_REACTIONS-CUTANEES_ANTI-IL1.pdf"
                  },
                  {
                    "F6_DEMYELINISANTES_ANTI-IL1_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/anti-IL1/Polyarthrite-Rhumatoide/Pathologies-que-faire-en-cas-d’antecedents-ou-d’apparition-de/F6_DEMYELINISANTES_ANTI-IL1.pdf"
                  },
                  {
                    "F7_INSUFFISANCE-HEPATIQUE_ANTI-IL1_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/anti-IL1/Polyarthrite-Rhumatoide/Pathologies-que-faire-en-cas-d’antecedents-ou-d’apparition-de/F7_INSUFFISANCE-HEPATIQUE_ANTI-IL1.pdf"
                  }
                ]
              },
              {
                "Situations cliniques : conduite à tenir en cas de_": [
                  {
                    "F10_CHIRURGIE_ANTI-IL1_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/anti-IL1/Polyarthrite-Rhumatoide/Situations-cliniques-conduite-a-tenir-en-cas-de/F10_CHIRURGIE_ANTI-IL1.pdf"
                  },
                  {
                    "F11_GROSSESSE_ANTI-IL1_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/anti-IL1/Polyarthrite-Rhumatoide/Situations-cliniques-conduite-a-tenir-en-cas-de/F11_GROSSESSE_ANTI-IL1.pdf"
                  },
                  {
                    "F12_ENFANT_4ANS_ANTI-IL1_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/anti-IL1/Polyarthrite-Rhumatoide/Situations-cliniques-conduite-a-tenir-en-cas-de/F12_ENFANT_4ANS_ANTI-IL1.pdf"
                  },
                  {
                    "F13_VACCINATION_ANTI-IL1_VDEF_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/anti-IL1/Polyarthrite-Rhumatoide/Situations-cliniques-conduite-a-tenir-en-cas-de/F13_VACCINATION_ANTI-IL1_VDEF.pdf"
                  },
                  {
                    "F14_VOYAGE_ANTI-IL1_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/anti-IL1/Polyarthrite-Rhumatoide/Situations-cliniques-conduite-a-tenir-en-cas-de/F14_VOYAGE_ANTI-IL1.pdf"
                  },
                  {
                    "F8_SITUATIONS-PARTICULIERES_ANTI-IL1_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/anti-IL1/Polyarthrite-Rhumatoide/Situations-cliniques-conduite-a-tenir-en-cas-de/F8_SITUATIONS-PARTICULIERES_ANTI-IL1.pdf"
                  },
                  {
                    "F9_ASSOCIATIONS-MEDICAMENTEUSE_ANTI-IL1_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/anti-IL1/Polyarthrite-Rhumatoide/Situations-cliniques-conduite-a-tenir-en-cas-de/F9_ASSOCIATIONS-MEDICAMENTEUSE_ANTI-IL1.pdf"
                  }
                ]
              },
              {
                "Utilisation des Anti-IL1 dans la PR : Information pour_": [
                  {
                    "F15A_ANTI-IL1_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/anti-IL1/Polyarthrite-Rhumatoide/Utilisation-des-Anti-IL1-dans-la-PR-Information-pour/F15A_ANTI-IL1.pdf"
                  },
                  {
                    "F15B_ANTI-IL1_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/anti-IL1/Polyarthrite-Rhumatoide/Utilisation-des-Anti-IL1-dans-la-PR-Information-pour/F15B_ANTI-IL1.pdf"
                  },
                  {
                    "F15C_ANTI-IL1_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/anti-IL1/Polyarthrite-Rhumatoide/Utilisation-des-Anti-IL1-dans-la-PR-Information-pour/F15C_ANTI-IL1.pdf"
                  }
                ]
              }
            ]
          }
        ]
      },
      {
        "anti-IL17": [
          {
            "Comment suivre et optimiser le traitement d’un patient sous anti-IL17 ?": [
              {
                "Anti_IL17_Suivi_Optimisation _pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/anti-IL17/Comment-suivre-et-optimiser-le-traitement-d’un-patient-sous-anti-IL17/Anti_IL17_Suivi_Optimisation .pdf"
              }
            ]
          },
          {
            "Conduite à tenir en cas :": [
              {
                "Anti_IL17_Asso_Med_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/anti-IL17/Conduite-a-tenir-en-cas-/Anti_IL17_Asso_Med.pdf"
              },
              {
                "Anti_IL17_Chirurgie_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/anti-IL17/Conduite-a-tenir-en-cas-/Anti_IL17_Chirurgie.pdf"
              },
              {
                "Anti_IL17_Grossesse_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/anti-IL17/Conduite-a-tenir-en-cas-/Anti_IL17_Grossesse.pdf"
              },
              {
                "Anti_IL17_Infection_BK_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/anti-IL17/Conduite-a-tenir-en-cas-/Anti_IL17_Infection_BK.pdf"
              },
              {
                "Anti_IL17_Infections_ViroBacterio_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/anti-IL17/Conduite-a-tenir-en-cas-/Anti_IL17_Infections_ViroBacterio.pdf"
              },
              {
                "Anti_IL17_Tatouage Piercing_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/anti-IL17/Conduite-a-tenir-en-cas-/Anti_IL17_Tatouage Piercing.pdf"
              },
              {
                "Anti_IL17_Vaccination_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/anti-IL17/Conduite-a-tenir-en-cas-/Anti_IL17_Vaccination.pdf"
              },
              {
                "Anti_IL17_Voyage_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/anti-IL17/Conduite-a-tenir-en-cas-/Anti_IL17_Voyage.pdf"
              },
              {
                "Anti_IL17_situations_part_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/anti-IL17/Conduite-a-tenir-en-cas-/Anti_IL17_situations_part.pdf"
              }
            ]
          },
          {
            "Que faire avant d’initier un anti-IL17 ?": [
              {
                "Anti_IL17_Bilan_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/anti-IL17/Que-faire-avant-d’initier-un-anti-IL17/Anti_IL17_Bilan.pdf"
              }
            ]
          },
          {
            "Que faire en cas d’antécédent ou d’apparition :": [
              {
                "Anti_IL17_Affections_Auto_Immu_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/anti-IL17/Que-faire-en-cas-d’antecedent-ou-d’apparition-/Anti_IL17_Affections_Auto_Immu.pdf"
              },
              {
                "Anti_IL17_Cardio_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/anti-IL17/Que-faire-en-cas-d’antecedent-ou-d’apparition-/Anti_IL17_Cardio.pdf"
              },
              {
                "Anti_IL17_Hemato_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/anti-IL17/Que-faire-en-cas-d’antecedent-ou-d’apparition-/Anti_IL17_Hemato.pdf"
              },
              {
                "Anti_IL17_Hepato_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/anti-IL17/Que-faire-en-cas-d’antecedent-ou-d’apparition-/Anti_IL17_Hepato.pdf"
              },
              {
                "Anti_IL17_Neoplasies_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/anti-IL17/Que-faire-en-cas-d’antecedent-ou-d’apparition-/Anti_IL17_Neoplasies.pdf"
              },
              {
                "Anti_IL17_Reaction_Cutanee_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/anti-IL17/Que-faire-en-cas-d’antecedent-ou-d’apparition-/Anti_IL17_Reaction_Cutanee.pdf"
              },
              {
                "Anti_IL17_mici_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/anti-IL17/Que-faire-en-cas-d’antecedent-ou-d’apparition-/Anti_IL17_mici.pdf"
              }
            ]
          }
        ]
      },
      {
        "anti-TNF": [
          {
            "Comment suivre et optimiser le traitement d’un patient sous anti-TNF ?": [
              {
                "Anti_TNF_Suivi_Optimisation_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/anti-TNF/Comment-suivre-et-optimiser-le-traitement-d’un-patient-sous-anti-TNF/Anti_TNF_Suivi_Optimisation.pdf"
              }
            ]
          },
          {
            "Comment utiliser les anti-TNF dans l’arthrite juvénile idiopathique ?": [
              {
                "Anti_TNF_AJI_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/anti-TNF/Comment-utiliser-les-anti-TNF-dans-l’arthrite-juvenile-idiopathique/Anti_TNF_AJI.pdf"
              }
            ]
          },
          {
            "Conduite à tenir en cas :": [
              {
                "Anti_TNF_Asso_Med_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/anti-TNF/Conduite-a-tenir-en-cas-/Anti_TNF_Asso_Med.pdf"
              },
              {
                "Anti_TNF_Chirurgie_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/anti-TNF/Conduite-a-tenir-en-cas-/Anti_TNF_Chirurgie.pdf"
              },
              {
                "Anti_TNF_Grossesse_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/anti-TNF/Conduite-a-tenir-en-cas-/Anti_TNF_Grossesse.pdf"
              },
              {
                "Anti_TNF_Infection_BK_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/anti-TNF/Conduite-a-tenir-en-cas-/Anti_TNF_Infection_BK.pdf"
              },
              {
                "Anti_TNF_Infections_ViroBacterio_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/anti-TNF/Conduite-a-tenir-en-cas-/Anti_TNF_Infections_ViroBacterio.pdf"
              },
              {
                "Anti_TNF_Pathologie_pulmonaire_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/anti-TNF/Conduite-a-tenir-en-cas-/Anti_TNF_Pathologie_pulmonaire.pdf"
              },
              {
                "Anti_TNF_Tatouage_Piercing_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/anti-TNF/Conduite-a-tenir-en-cas-/Anti_TNF_Tatouage_Piercing.pdf"
              },
              {
                "Anti_TNF_Vaccination_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/anti-TNF/Conduite-a-tenir-en-cas-/Anti_TNF_Vaccination.pdf"
              },
              {
                "Anti_TNF_Voyage_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/anti-TNF/Conduite-a-tenir-en-cas-/Anti_TNF_Voyage.pdf"
              },
              {
                "Anti_TNF_situations_part_04042021_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/anti-TNF/Conduite-a-tenir-en-cas-/Anti_TNF_situations_part_04042021.pdf"
              }
            ]
          },
          {
            "Les anti-TNF biosimilaires dans les rhumatismes inflammatoires": [
              {
                "Anti_TNF_Biosimilaire_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/anti-TNF/Les-anti-TNF-biosimilaires-dans-les-rhumatismes-inflammatoires/Anti_TNF_Biosimilaire.pdf"
              }
            ]
          },
          {
            "Que faire avant d’initier un anti-TNF ?": [
              {
                "Anti_TNF_Bilan_04042021_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/anti-TNF/Que-faire-avant-d’initier-un-anti-TNF/Anti_TNF_Bilan_04042021.pdf"
              }
            ]
          },
          {
            "Que faire en cas d’antécédent ou d’apparition :": [
              {
                "Anti_TNF_Affections_Auto_Immu_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/anti-TNF/Que-faire-en-cas-d’antecedent-ou-d’apparition-/Anti_TNF_Affections_Auto_Immu.pdf"
              },
              {
                "Anti_TNF_Cardio_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/anti-TNF/Que-faire-en-cas-d’antecedent-ou-d’apparition-/Anti_TNF_Cardio.pdf"
              },
              {
                "Anti_TNF_Hemato_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/anti-TNF/Que-faire-en-cas-d’antecedent-ou-d’apparition-/Anti_TNF_Hemato.pdf"
              },
              {
                "Anti_TNF_Hepato_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/anti-TNF/Que-faire-en-cas-d’antecedent-ou-d’apparition-/Anti_TNF_Hepato.pdf"
              },
              {
                "Anti_TNF_Neoplasies_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/anti-TNF/Que-faire-en-cas-d’antecedent-ou-d’apparition-/Anti_TNF_Neoplasies.pdf"
              },
              {
                "Anti_TNF_Reaction_Cutanee_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/anti-TNF/Que-faire-en-cas-d’antecedent-ou-d’apparition-/Anti_TNF_Reaction_Cutanee.pdf"
              }
            ]
          }
        ]
      },
      {
        "belimumab": [
          {
            "Bilan Pré-Thérapeutique": [
              {
                "F1_BILAN_PRE-THERAPEUTIQUE_VDEF_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/belimumab/Bilan-Pre-Therapeutique/F1_BILAN_PRE-THERAPEUTIQUE_VDEF.pdf"
              }
            ]
          },
          {
            "Pathologies : que faire en cas d'antécédents ou d'apparition de_": [
              {
                "F10_ATTEINTE_NEUROLOGIQUE_VDEF_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/belimumab/Pathologies--que-faire-en-cas-dantecedents-ou-dapparition-de/F10_ATTEINTE_NEUROLOGIQUE_VDEF.pdf"
              },
              {
                "F11_REACTIONS_INJECTION_VDEF_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/belimumab/Pathologies--que-faire-en-cas-dantecedents-ou-dapparition-de/F11_REACTIONS_INJECTION_VDEF.pdf"
              },
              {
                "F3_INFECTIONS_BACTERIENNES_ET_VIRALES_VDEF_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/belimumab/Pathologies--que-faire-en-cas-dantecedents-ou-dapparition-de/F3_INFECTIONS_BACTERIENNES_ET_VIRALES_VDEF.pdf"
              },
              {
                "F4_NEOPLASIES_SOLIDES_VDEF_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/belimumab/Pathologies--que-faire-en-cas-dantecedents-ou-dapparition-de/F4_NEOPLASIES_SOLIDES_VDEF.pdf"
              },
              {
                "F6_ATTEINTE_CARDIOVASCULAIRE_VDEF_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/belimumab/Pathologies--que-faire-en-cas-dantecedents-ou-dapparition-de/F6_ATTEINTE_CARDIOVASCULAIRE_VDEF.pdf"
              },
              {
                "F7_ATTEINTE_RENALE_VDEF_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/belimumab/Pathologies--que-faire-en-cas-dantecedents-ou-dapparition-de/F7_ATTEINTE_RENALE_VDEF.pdf"
              },
              {
                "F8_ATTEINTE_HEPATIQUE_VDEF_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/belimumab/Pathologies--que-faire-en-cas-dantecedents-ou-dapparition-de/F8_ATTEINTE_HEPATIQUE_VDEF.pdf"
              },
              {
                "F9_ATTEINTE_HEMATOLOGIQUE_VDEF_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/belimumab/Pathologies--que-faire-en-cas-dantecedents-ou-dapparition-de/F9_ATTEINTE_HEMATOLOGIQUE_VDEF.pdf"
              }
            ]
          },
          {
            "Situation Clinique : conduite à tenir en cas de_": [
              {
                "F12_DYALISE_HEMOGLOBINOPATHIE_SPLENECTOMIE_VDEF_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/belimumab/Situation-Clinique--conduite-a-tenir-en-cas-de/F12_DYALISE_HEMOGLOBINOPATHIE_SPLENECTOMIE_VDEF.pdf"
              },
              {
                "F13_ASSOCIATIONS_MEDICAMENTEUSE_VDEF_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/belimumab/Situation-Clinique--conduite-a-tenir-en-cas-de/F13_ASSOCIATIONS_MEDICAMENTEUSE_VDEF.pdf"
              },
              {
                "F14_CHIRURGIE_SOINS_DENTAIRES_BRULURE_TRAUMATISMES_VDEF_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/belimumab/Situation-Clinique--conduite-a-tenir-en-cas-de/F14_CHIRURGIE_SOINS_DENTAIRES_BRULURE_TRAUMATISMES_VDEF.pdf"
              },
              {
                "F15_GROSSESSE_VDEF_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/belimumab/Situation-Clinique--conduite-a-tenir-en-cas-de/F15_GROSSESSE_VDEF.pdf"
              },
              {
                "F16_VACCINATION_VDEF_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/belimumab/Situation-Clinique--conduite-a-tenir-en-cas-de/F16_VACCINATION_VDEF.pdf"
              },
              {
                "F17_VOYAGE_VDEF_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/belimumab/Situation-Clinique--conduite-a-tenir-en-cas-de/F17_VOYAGE_VDEF.pdf"
              }
            ]
          },
          {
            "Suivi Thérapeutique": [
              {
                "F2_SUIVI_THERAPEUTIQUE_VDEF_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/belimumab/Suivi-Therapeutique/F2_SUIVI_THERAPEUTIQUE_VDEF.pdf"
              }
            ]
          },
          {
            "Utilisation du belimumab au cours du lupus systémique": [
              {
                "F18_INFO_PATIENT_LUPUS_VDEF_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/belimumab/Utilisation-du-belimumab-au-cours-du-lupus-systemique/F18_INFO_PATIENT_LUPUS_VDEF.pdf"
              }
            ]
          },
          {
            "annexes": [
              {
                "F19_MED_SPE_CORRESPONDANT_VDEF_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/belimumab/annexes/F19_MED_SPE_CORRESPONDANT_VDEF.pdf"
              },
              {
                "F20_MED_SPE_TRAITANT_VDEF_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/belimumab/annexes/F20_MED_SPE_TRAITANT_VDEF.pdf"
              }
            ]
          }
        ]
      },
      {
        "inhibiteurs de Janus Kinases (JAKi)": [
          {
            "Dans la polyarthrite rhumatoïde modérée à sévère": [
              {
                "Comment optimiser le traitement par JAKi ?": [
                  {
                    "JAK_03_Optimisation_VDEF_1218_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/inhibiteurs-de-Janus-Kinases-(JAKi)/Dans-la-polyarthrite-rhumatoide-moderee-a-severe/Comment-optimiser-le-traitement-par-JAKi/JAK_03_Optimisation_VDEF_1218.pdf"
                  }
                ]
              },
              {
                "Comment suivre un patient traité par JAKi ? ": [
                  {
                    "JAK_02_Suivi TP_MAJ_220719_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/inhibiteurs-de-Janus-Kinases-(JAKi)/Dans-la-polyarthrite-rhumatoide-moderee-a-severe/Comment-suivre-un-patient-traite-par-JAKi/JAK_02_Suivi TP_MAJ_220719.pdf"
                  }
                ]
              },
              {
                "Exemple de lettre d’information au_": [
                  {
                    "JAK_15_Lettre rhumato_MAJ_220719_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/inhibiteurs-de-Janus-Kinases-(JAKi)/Dans-la-polyarthrite-rhumatoide-moderee-a-severe/Exemple-de-lettre-d’information-au/JAK_15_Lettre rhumato_MAJ_220719.pdf"
                  },
                  {
                    "JAK_16_Lettre-au-medecin-traitant_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/inhibiteurs-de-Janus-Kinases-(JAKi)/Dans-la-polyarthrite-rhumatoide-moderee-a-severe/Exemple-de-lettre-d’information-au/JAK_16_Lettre-au-medecin-traitant.pdf"
                  }
                ]
              },
              {
                "Pathologies : que faire en cas d’antécédent ou d’apparition de_": [
                  {
                    "JAK_04_ Infections viro_MAJ_220719_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/inhibiteurs-de-Janus-Kinases-(JAKi)/Dans-la-polyarthrite-rhumatoide-moderee-a-severe/Pathologies--que-faire-en-cas-d’antecedent-ou-d’apparition-de/JAK_04_ Infections viro_MAJ_220719.pdf"
                  },
                  {
                    "JAK_05_ Infections bact_09102018_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/inhibiteurs-de-Janus-Kinases-(JAKi)/Dans-la-polyarthrite-rhumatoide-moderee-a-severe/Pathologies--que-faire-en-cas-d’antecedent-ou-d’apparition-de/JAK_05_ Infections bact_09102018.pdf"
                  },
                  {
                    "JAK_06_ Cardio_MAJ_220719_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/inhibiteurs-de-Janus-Kinases-(JAKi)/Dans-la-polyarthrite-rhumatoide-moderee-a-severe/Pathologies--que-faire-en-cas-d’antecedent-ou-d’apparition-de/JAK_06_ Cardio_MAJ_220719.pdf"
                  },
                  {
                    "JAK_07_Cancer_MAJ_220719_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/inhibiteurs-de-Janus-Kinases-(JAKi)/Dans-la-polyarthrite-rhumatoide-moderee-a-severe/Pathologies--que-faire-en-cas-d’antecedent-ou-d’apparition-de/JAK_07_Cancer_MAJ_220719.pdf"
                  },
                  {
                    "JAK_08_Aff Hemato_MAJ_200819_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/inhibiteurs-de-Janus-Kinases-(JAKi)/Dans-la-polyarthrite-rhumatoide-moderee-a-severe/Pathologies--que-faire-en-cas-d’antecedent-ou-d’apparition-de/JAK_08_Aff Hemato_MAJ_200819.pdf"
                  },
                  {
                    "JAK_09_Digestif_Hepatiq_MAJ_220719_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/inhibiteurs-de-Janus-Kinases-(JAKi)/Dans-la-polyarthrite-rhumatoide-moderee-a-severe/Pathologies--que-faire-en-cas-d’antecedent-ou-d’apparition-de/JAK_09_Digestif_Hepatiq_MAJ_220719.pdf"
                  }
                ]
              },
              {
                "Que faire avant d’initier les inhibiteurs de JAK (JAKi) ?": [
                  {
                    "JAK_01_Bilan préthérapeutique_MAJ_220719_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/inhibiteurs-de-Janus-Kinases-(JAKi)/Dans-la-polyarthrite-rhumatoide-moderee-a-severe/Que-faire-avant-d’initier-les-inhibiteurs-de-JAK-(JAKi)/JAK_01_Bilan préthérapeutique_MAJ_220719.pdf"
                  }
                ]
              },
              {
                "Situations cliniques : quelle conduite à tenir en cas de_": [
                  {
                    "JAK_10_Chirurgie_VDEF_1218_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/inhibiteurs-de-Janus-Kinases-(JAKi)/Dans-la-polyarthrite-rhumatoide-moderee-a-severe/Situations-cliniques--quelle-conduite-a-tenir-en-cas-de/JAK_10_Chirurgie_VDEF_1218.pdf"
                  },
                  {
                    "JAK_11_Grossesse_VDEF_1218_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/inhibiteurs-de-Janus-Kinases-(JAKi)/Dans-la-polyarthrite-rhumatoide-moderee-a-severe/Situations-cliniques--quelle-conduite-a-tenir-en-cas-de/JAK_11_Grossesse_VDEF_1218.pdf"
                  },
                  {
                    "JAK_12_Vaccination_VDEF_1218_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/inhibiteurs-de-Janus-Kinases-(JAKi)/Dans-la-polyarthrite-rhumatoide-moderee-a-severe/Situations-cliniques--quelle-conduite-a-tenir-en-cas-de/JAK_12_Vaccination_VDEF_1218.pdf"
                  },
                  {
                    "JAK_13_Voyage_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/inhibiteurs-de-Janus-Kinases-(JAKi)/Dans-la-polyarthrite-rhumatoide-moderee-a-severe/Situations-cliniques--quelle-conduite-a-tenir-en-cas-de/JAK_13_Voyage.pdf"
                  },
                  {
                    "JAK_14_Association_Med_VDEF_1218_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/inhibiteurs-de-Janus-Kinases-(JAKi)/Dans-la-polyarthrite-rhumatoide-moderee-a-severe/Situations-cliniques--quelle-conduite-a-tenir-en-cas-de/JAK_14_Association_Med_VDEF_1218.pdf"
                  }
                ]
              }
            ]
          },
          {
            "Dans les maladies hors PR": [
              {
                "Comment utiliser les inhibiteurs de JAK (JAKi) dans_": [
                  {
                    "JAK_17_Connectivites_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/inhibiteurs-de-Janus-Kinases-(JAKi)/Dans-les-maladies-hors-PR/Comment-utiliser-les-inhibiteurs-de-JAK-(JAKi)-dans/JAK_17_Connectivites.pdf"
                  },
                  {
                    "JAK_18_Spondyloarthrites_MAJ_220719_pdf": "https://f.360medics.com/pdfviewer/index.html?f=https://med-cdn.ams3.digitaloceanspaces.com/assets/media/ref-sfr/CRI/inhibiteurs-de-Janus-Kinases-(JAKi)/Dans-les-maladies-hors-PR/Comment-utiliser-les-inhibiteurs-de-JAK-(JAKi)-dans/JAK_18_Spondyloarthrites_MAJ_220719.pdf"
                  }
                ]
              }
            ]
          }
        ]
      }
    ]
  }
]
